Pillstats
Rx only · Injection · Intravenous

Epinephrine

Epinephrine

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3992
US makers8 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.349$0.697$1.05$1.39Dec 2025Apr 2026Jul 2026
$1.213
Latest avg · Jul 22, 2026
+1%
Since Dec 17, 2025
8
Active US suppliers
33%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3186359531.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
988
Rx · 2026 Q1
26K
Units dispensed
+3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
HF Acquisition Co LLC, DBA HealthFirstunknown2SUPPLYING
ProPharma Distributionunknown1SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
BPI Labs LLCunknown1SUPPLYING
REMEDYREPACK INC.repackager1SUPPLYING
Henry Schein Inc.unknown1SUPPLYING
International Medication Systems, Limitedunknown1SUPPLYING
Medical Purchasing Solutions, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 1, 2026
    RECALLRecall (Class II): EPINEPHRINE Injection, USP, 1 mg/10mL (0.1 mg/mL), Rx only, INTERNATIONAL MEDICATION SYSTEMS, LIMITED, So. EL Monte, CA…

    Lack of Assurance of Sterility — Recalling firm: International Medication Systems Ltd. — U.S. Nationwide